Research Topics
Species | Armando E GiulianoSummaryAffiliation: Cedars-Sinai Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?Armando E Giuliano
Department of Surgery, Cedars Sinai Medical Center, Los Angeles, CA, USA
Clin Exp Metastasis 29:687-92. 2012..SLNR has its role in the management of early stage breast cancer, but whether SLNR alone should replace ALND is yet to be determined...- Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancerArmando E Giuliano
Division of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California, USA
JAMA 306:385-93. 2011..Immunochemical staining of sentinel lymph nodes (SLNs) and bone marrow identifies breast cancer metastases not seen with routine pathological or clinical examination... - Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trialArmando E Giuliano
John Wayne Cancer Institute at Saint John s Health Center, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
JAMA 305:569-75. 2011..Sentinel lymph node dissection (SLND) accurately identifies nodal metastasis of early breast cancer, but it is not clear whether further nodal dissection affects survival... 
Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010Lee G Wilke
Department of Surgery, Duke University Medical Center, Durham, NC, USA
Ann Surg Oncol 17:1989-94. 2010..We proposed to study the degree of adherence with these measures among participating institutions in a multi-institutional trial...- Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trialArmando E Giuliano
John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA 90404, USA
Ann Surg 252:426-32; discussion 432-3. 2010..Few studies have examined the outcome of patients who do not undergo ALND for positive SNs. We now report local and regional recurrence information from the American College of Surgeons Oncology Group Z0011 trial... 
Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugsValerie Gouaze
John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California 90404, USA
Cancer Res 65:3861-7. 2005..The data suggest that lipids play a role in the expression of multidrug resistance...- Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodesTaku Nakagawa
Department of Molecular Oncology, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, California 90404, USA
Clin Cancer Res 13:4105-10. 2007.... - Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort studyAnneke Q van Hoesel
Department of Molecular Oncology, John Wayne Cancer Institute JWCI at St John s Health Center, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
Breast Cancer Res Treat 134:1103-14. 2012..LINE-1 analysis of primary breast cancer demonstrated cancer-related age-dependent hypomethylation. In patients ≤55 years, LINE-1 hypomethylation portends a high-risk of DR... - Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancerKatherine E Posther
Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA
Ann Surg 242:593-9; discussion 599-602. 2005.... - Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancerA Marilyn Leitch
Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9155, USA
Am J Surg 190:539-42. 2005..This report elucidates factors influencing patient accrual... - Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011John A Olson
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
J Clin Oncol 26:3530-5. 2008..The impact of the timing of cALND on pathologic results and complications in these patients has not been examined... - The current role of sentinel node biopsy in the treatment of breast cancerBaiba J Grube
Department of Surgery, University of Texas Medical Branch, Galveston, Texas, USA
Adv Surg 38:121-66. 2004 - Proteomic profiling of primary breast cancer predicts axillary lymph node metastasisTaku Nakagawa
Department of Molecular Oncology, Division of Biostatistics, and Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute, Santa Monica, CA 90404, USA
Cancer Res 66:11825-30. 2006..016 and 0.0083, respectively). ProteinChip array analysis identified differential protein peaks in primary breast cancers that predict the presence and number of ALN metastases and non-SLN status... - Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasisMasaru Shinozaki
Department of Molecular Oncology, John Wayne Cancer Institute and St. John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
Clin Cancer Res 11:2156-62. 2005.... - Prognostic value of basal phenotype in HER2-overexpressing breast cancerSanjay P Bagaria
Department of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA, USA
Ann Surg Oncol 19:935-40. 2012..We investigated the clinical relevance of this basal-HER2+ subtype within HER2-overexpressing breast tumors... - Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imagingHiroya Takeuchi
Department of Molecular Oncology, John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
J Clin Endocrinol Metab 92:1785-90. 2007.... - Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional auditKatrina H Moore
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, MRI 1026, New York, NY 10021, USA
Ann Surg Oncol 14:2911-7. 2007..Although it is well established that nodal status for invasive disease is prognostically important, the clinical relevance of a positive SLN in patients with DCIS remains undetermined... - Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical studyPARTHA S RAY
Department of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA, USA
Ann Surg Oncol 18:3839-47. 2011..We investigated the prognostic value of FOXC1 protein expression in invasive breast cancer and compared its prognostic significance to that of TNP and basal CKs... - An update on prognosis in breast cancer patients with extensive axillary diseaseFrancesca Hoehne
Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California 90404, USA
Breast J 14:76-80. 2008..14 (95% confidence interval: 0.04-0.46). In our study, patients with at least 10 positive axillary LN had a 5-year survival of 71.9% which may be due to the improvements in local and systemic therapy... - Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cellsValerie Gouaze-Andersson
John Wayne Cancer Institute at Saint John s Health Center, Department of Experimental Therapeutics, Santa Monica, CA 90404, USA
Biochim Biophys Acta 1771:1407-17. 2007..Therefore, ceramide's role as a messenger of cytotoxic response might be linked to the multidrug resistance pathway... - Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinomaJoseph Kim
Department of Molecular Oncology, John Wayne Cancer Institute at Saint Johns Hospital, Santa Monica, CA 90404, USA
Ann Surg 244:799-804. 2006..To define the role of BRAF gene mutation in the progression of papillary thyroid carcinoma... - Prediction of breast tumor progression by integrity of free circulating DNA in serumNaoyuki Umetani
Department of Molecular Oncology and the Joyce Eisenberg Breast Center, John Wayne Cancer Institute, Santa Monica, CA 90404, USA
J Clin Oncol 24:4270-6. 2006..0002 and P < .0001, respectively). CONCLUSION: Integrity of serum circulating DNA is a promising molecular biomarker for detecting breast cancer tumor progression and regional LN metastases... - Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomesNabil Wasif
John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
Ann Surg Oncol 17:1862-9. 2010..Does delayed diagnosis of ILC affect survival? We used a national registry to compare outcomes of patients with stage-matched ILC and IDC... - Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trialLee Gravatt Wilke
Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA
Ann Surg Oncol 13:491-500. 2006..CONCLUSIONS: This study provides a prospective assessment of the sentinel lymph node biopsy procedure, as performed by a wide range of surgeons, demonstrating a low complication rate... - Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapyBret Taback
Division of Surgical Oncology, Columbia University Medical Center, 177 Fort Washington Avenue, New York, New York 10032, USA
Ann Surg Oncol 13:1099-104. 2006..This approach illustrates variations in the lymphatic drainage of recurrent breast tumors and may permit the identification of regional metastasis not noted with conventional imaging techniques... - Epigenetic regulation of cancer stem cell genes in triple-negative breast cancerNaofumi Kagara
Department of Molecular Oncology, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA 90404, USA
Am J Pathol 181:257-67. 2012..Assessment of epigenetic changes in BCSC genes may provide a more accurate classification of TNBC and could be developed as potential therapeutic targets... - Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancerEiji Sunami
Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA
Ann N Y Acad Sci 1137:171-4. 2008..This preliminary study demonstrates the potential clinical utility of LINE1 copy numbers in breast cancer patients... - Impact of micrometastases in the sentinel node of patients with invasive breast cancerNora M Hansen
John Wayne Cancer Institute, Santa Monica, CA 90404, USA
J Clin Oncol 27:4679-84. 2009..This study is based on the new sixth edition of the American Joint Committee on Cancer (AJCC) staging criteria... - Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumorsEiji Sunami
Department of Molecular Oncology, The John Wayne Cancer Institute, Saint John s Health Center, Santa Monica Blvd, Santa Monica, California 90404, USA
Breast Cancer Res 10:R46. 2008.... - Tumor characteristics predictive of sentinel node metastases in 105 consecutive patients with invasive lobular carcinomaBaiba J Grube
Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA 90404, USA
Am J Surg 184:372-6. 2002..CONCLUSIONS: SN staging for ILC is feasible and accurate. Receptor status and proliferative indices are not useful markers for metastases. However, large tumor size and presence of angiolymphatic invasion are positive predictors... - Sentinel node mapping for breast cancer: progress to date and prospects for the futureHelen Mabry
John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
Surg Oncol Clin N Am 16:55-70. 2007..SNB has become the new standard of care for the treatment of early breast cancer... - Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancerRebecca Crane-Okada
Department of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
Ann Surg Oncol 15:1996-2005. 2008..The purpose of this study was to compare long-term morbidity after SLNB or ALND and breast-conservation surgery... - Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patientsBret Taback
Department of Molecular Oncology, Joyce Eisenberg-Keefer Breast Center, John Wayne Cancer Institute, Santa Monica, California 90404, USA
Cancer Res 63:1884-7. 2003.... - Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancerNabil Wasif
John Wayne Cancer Institute at Saint John s Health Center, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
Arch Surg 145:161-6. 2010..Current American Society of Clinical Oncology guidelines for management of sentinel node micrometastases (SNMM) in breast cancer recommend axillary lymph node dissection (ALND) for all patients... - Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancerNora M Hansen
Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, Calif, USA
Arch Surg 139:634-9; discussion 639-40. 2004..The incidence of sentinel node (SN) metastases from invasive breast cancer might be affected by the technique used to obtain biopsy specimens from the primary tumor before sentinel lymph node dissection... - FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancerPARTHA S RAY
Department of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
Cancer Res 70:3870-6. 2010..Our findings identify FOXC1 as a theranostic biomarker that is specific for BLBC, offering not only a potential prognostic candidate but also a potential molecular therapeutic target in this breast cancer subtype... - Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patientsBret Taback
Division of Surgical Oncology, Columbia University Medical Center, New York, New York 10032, USA
Ann N Y Acad Sci 1075:211-21. 2006..This study demonstrates the novel finding of tumor-associated epigenetic markers in BM aspirates/blood and their potential role as targets for molecular detection... - Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialtyNabil Wasif
John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
Ann Surg Oncol 16:2442-9. 2009..We hypothesized that variation exists in adherence to these guidelines and management of SNMM as a result of the medical specialty of the treating physician... - Axillary dissection is not required for all patients with breast cancer and positive sentinel nodesJ Michael Guenther
Kaiser Los Angeles Medical Center, Los Angeles, CA, USA
Arch Surg 138:52-6. 2003..To confirm this observation, we suggest that patients with SN metastases are ideal candidates for trials evaluating the necessity of ALND... - The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?Sanjay P Bagaria
Department of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
Ann Surg Oncol 18:1845-51. 2011..Since DCIS is considered a precursor to invasive ductal carcinoma, should F-LCIS be considered a precursor to invasive lobular carcinoma (ILC)?.. - MRI versus ultrasonography and mammography for preoperative assessment of breast cancerNabil Wasif
John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California 90404, USA
Am Surg 75:970-5. 2009..We conclude that MRI is more accurate than either ultrasonography or mammography for assessment of the size of primary breast cancer presenting as a mass... - N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killingHongtao Wang
Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
Mol Cancer Ther 7:2967-76. 2008..These studies suggest that enhanced clinical efficacy of 4-HPR may be realized through regimens containing agents that modulate sphingoid base metabolism... - Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissectionKristine E Calhoun
The Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
Am J Surg 190:588-91. 2005..3% had micrometastases. When ALND was not performed, axillary recurrence was not seen. The low risk of non-SLN disease in this study fails to support the routine use of ALND for ITC-positive SLNs... - The prognostic significance of micrometastases in breast cancer: a SEER population-based analysisSteven L Chen
Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute, Saint John s Health Center, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
Ann Surg Oncol 14:3378-84. 2007..We hypothesized that the survival of patients with solely micrometastatic disease (N1mi) would be intermediate to patients with 1-3 tumor-positive lymph nodes (N1) and those with no positive lymph nodes (N0)... - Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapyValerie Gouaze
John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California 90404, USA
Mol Cancer Ther 3:633-9. 2004..A possible connection between glucosylceramide synthase and P-gp in drug resistance biology is suggested... - Direct serum assay for microRNA-21 concentrations in early and advanced breast cancerSota Asaga
Department of Molecular Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA 90404, USA
Clin Chem 57:84-91. 2011..We hypothesized that serum concentrations of miR-21, a biomarker increased in breast tumors, would correlate with the presence and extent of breast cancer... - What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?Helen Mabry
Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
Am J Surg 192:455-7. 2006..Some surgeons have advocated sentinel node biopsy (SNB) for ductal carcinoma in situ (DCIS). The value of the information obtained is not clear... - Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007Armando E Giuliano
John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
Ann Surg Oncol 14:2425-7. 2007 - Sentinel lymph node biopsy for papillary thyroid cancer: 12 years of experience at a single institutionDeborah K Cunningham
Department of Surgical Oncology, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA, USA
Ann Surg Oncol 17:2970-5. 2010.... - Surgical delay of the nipple-areolar complex: a powerful technique to maximize nipple viability following nipple-sparing mastectomyJ Arthur Jensen
Division of Plastic Surgery, Geffen School of Medicine at U C L A, Los Angeles, CA, USA
Ann Surg Oncol 19:3171-6. 2012..We used a surgical delay procedure to improve nipple viability in patients who were identified to be at high risk for nipple necrosis following NSM... - Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancerAnneke Q van Hoesel
Department of Molecular Oncology, John Wayne Cancer Institute JWCI at St John s Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA, 90404, USA
Breast Cancer Res Treat 131:859-69. 2012..0, P = 0.003). Methylation classification of primary breast cancer is an independent prognostic factor for disease outcome in patients with ER-negative tumors. The study's findings will have to be confirmed in an independent dataset... - A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodesSheldon Feldman
Department of Surgery, Columbia University College of Physicians and Surgeons, New York, New York, USA
Cancer 117:2599-607. 2011.... - B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasisTakaaki Arigami
Department of Molecular Oncology, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA, USA
Ann Surg 252:1044-51. 2010..We hypothesized that B7-H3, a coinhibitory factor, is expressed by primary breast cancer cells and associated with metastasis to regional tumor-draining lymph nodes... - Nipple-sparing mastectomy in 99 patients with a mean follow-up of 5 yearsJ Arthur Jensen
Department of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
Ann Surg Oncol 18:1665-70. 2011..The safety and practicality of nipple-sparing mastectomy (NSM) are controversial... - Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancerSteven D Trocha
Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John s Health Center, 2200 Santa Monica Blvd Suite, 113, Santa Monica, CA, 90404, USA
Surg Oncol 12:271-6. 2003.... - Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based trainingRoderick R Turner
Department of Pathology, Saint John s Health Center, 1328 Twenty Second St, Santa Monica, CA 90404, USA
J Clin Oncol 26:258-63. 2008..We sought to determine whether a set of clearly defined histologic criteria could lead to reproducible nodal classification by pathologists... - Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approachesJacqueline V Chapman
John Wayne Cancer Institute at Saint John s Health Center, Department of Experimental Therapeutics, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
Biochem Pharmacol 80:308-15. 2010..We propose that use of tamoxifen and other P-glycoprotein antagonists can be an effective means for enhancing cytotoxic potential of short-chain ceramides in the treatment of cancer... - Sentinel lymph node mapping for primary breast cancerLori L Wilson
Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at St. John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
Curr Oncol Rep 7:12-7. 2005..We address the current status and future directions of SLND for primary breast cancer... - Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancerNaoyuki Umetani
Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, CA 90404, USA
Oncogene 24:4721-7. 2005..ID4 mRNA level was suppressed in hypermethylated cancer specimens (P=0.014). ID4 may play an important suppressive role in tumor progression, and its silencing by hypermethylation may increase the risk of regional lymph node metastasis... - Sentinel lymph node dissection and the current status of American trials on breast lymphatic mappingKatherine E Posther
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
Semin Oncol 31:426-36. 2004..Surgeon participation is crucial to the ongoing success of clinical trials in the field of breast cancer surgery... - Comparison of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancerAlice P Chung
Department of Surgery, Division of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
J Am Coll Surg 215:137-46; discussion 146-7. 2012..There is controversy about whether breast conserving therapy (BCT) should be contraindicated in multifocal (MF) breast cancer. Few studies have reported on the oncologic safety of BCT in MF breast cancer... - Preoperative breast MRI in the surgical treatment of ductal carcinoma in situLuisa C Kropcho
Departments of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
Breast J 18:151-6. 2012..In this study, MRI did not improve the surgeon's ability to achieve clear margins following BCS... - Local and regional control in breast cancer: role of sentinel node biopsyArmando E Giuliano
Margie and Robert E Petersen Breast Cancer Research Program, John Wayne Cancer Institute at Saint John s Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
Adv Surg 45:101-16. 2011.... - Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancerRobert A Wascher
Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
Clin Cancer Res 9:1427-35. 2003..CONCLUSIONS: STC-1 is proposed as a novel, specific, and clinically useful molecular marker for detecting occult breast cancer cells in the BM and blood... - The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancerNancy C Greep
Department of Skeletal Health, The John Wayne Cancer Institute at Saint John's Hospital, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
Am J Med 114:653-9. 2003..Whether this effect is caused by adjuvant chemotherapy remains to be determined... - Skin-sparing mastectomy. specialty bias and worldwide lack of consensusRichard J Bleicher
John Wayne Cancer Institute, Saint John's Hospital and Health Center, Santa Monica, California 90404, USA
Cancer 98:2316-21. 2003..Although these results were indicative of only those responding, education about SSM is needed across specialties and in other countries if the procedure is to be widely accepted... - Senior peer counseling by telephone for psychosocial support after breast cancer surgery: effects at six monthsRebecca Crane-Okada
John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA, USA
Oncol Nurs Forum 39:78-89. 2012..To evaluate the efficacy of senior peer counseling by telephone for supplemental psychosocial support of older women after breast cancer surgery... - Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cellsYong Yu Liu
John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
J Lipid Res 45:933-40. 2004..This study demonstrates that a 20-mer asGCS oligonucleotide effectively reverses MDR in human cancer cells... - The selective use of sentinel node biopsy in ductal carcinoma in situRichard J Bleicher
John Wayne Cancer Institute, Santa Monica, CA 90404, USA
Arch Surg 138:489. 2003 - Weight of normal parathyroid glands in patients with parathyroid adenomasKathy Yao
Department of Breast and Endocrine Disease, John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
J Clin Endocrinol Metab 89:3208-13. 2004..Therefore, certain histological features are a better measure than weight in determining whether a gland is normal, and intraoperative identification of slightly enlarged glands should not lead to immediate subtotal parathyroidectomy... - The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastasesSteve R Martinez
Department of Surgical Oncology, Division of Gastrointestinal Surgery, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
Am J Surg 191:281-3. 2006..Hepatic metastases from breast cancer signal a dismal prognosis, with a median survival of 9.5 months... - Molecular lymphatic mapping of the sentinel lymph nodeBret Taback
Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California 90404, USA
Am J Pathol 161:1153-61. 2002..MLM in conjunction with a conventional mapping agent can be used as a valuable asset for molecular assessment of the SLN and retrospective analysis of paraffin-embedded specimens... - The time has come to change the algorithm for the surgical management of early breast cancerNora M Hansen
Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at St John s Health Center, Santa Monica, CA 90404, USA
Arch Surg 137:1131-5. 2002..If the sentinel lymph nodes (SNs) draining a primary invasive breast cancer are free of tumor, then axillary lymph node dissection is not necessary for management of disease...